Centchroman Regress Mastalgia and Fibroadenoma: An Institutional Study
Journal Title: Journal of Medical Science And clinical Research - Year 2016, Vol 4, Issue 7
Abstract
Objectives: Centchroman (also known as Ormeloxifene) is one of the selective estrogen receptor modulators, or SERMs, a class of medication which acts selectively on the estrogen receptor. Because of its selective antiestrogen action, centchroman has been used for treatment of mastalgia and fibroadenoma. Materials And Methods: Benign breast disease patients up to 35 years of age attending surgery outpatient department from August 2012 to September 2014 and fulfilling inclusion criterion were included in the study. The patients were started on centchroman 30 mg on daily for a period of 12 weeks and were followed at weeks 4, 8, 12, and 24 to assess response to therapy. The Results were recorded as per clinical examination, ultrasonography for breast lump size and visual analog scale (VAS) for pain. Results: A total of 130 patients were included in the study, 88 (67.70%) of whom had mastalgia with or without nodularity, and 42 (32.30%) had fibroadenoma. Noncyclical pain was in 71 patients (80.70%), and cyclical pain was recorded in only 17 (19.30%) patients. A VAS score of 10 was recorded by 62 (70.50%) patients (severe pain), and the remaining 26 patients (29.50%) had VAS score from 7 to 10. Fibroadenoma size ranged from 1.5 to 5 cm, single or multiple in one or both breast. There was a good response in the mastalgia group, with a decrease in the VAS scoring from 10 to 3 in 69 (78.40%) of the patients in the first week. Almost all of the patients were painless at the end of first month, with complete disappearance of the nodularity. In the fibroadenoma group there was a mixed response, with complete disappearance in 21 (35%), partial regression (decrease in volume of fibroadenoma) in 29 (48.30%) and no response at all in the remaining 10 (16.70%) a period of 6 months. There were few side effects with scanty menses or amenorrhea as the only side effect. Conclusions: Centchroman is a safe drug for the treatment of mastalgia and fibroadenoma. It has shown good results in mastalgia and fibroadenoma, is an effective, safe and inexpensive
Authors and Affiliations
Bhupender Sharma
Keywords
Related Articles
- EP ID EP213807
- DOI -
- Views 72
- Downloads 0
Biomedical Waste Management: A Study of Knowledge, Practices and Attitude among Health Care Personnel at a Tertiary Care Hospital in Bhopal, Central India
Inadequate and inappropriate knowledge of handling biomedical waste (BMW) among health care personnel may have serious health consequences and a significant impact on the environment as well. In view of this, present stu...
Effectiveness of Polymerase chain reaction in Ziehl-Neelsen stain negative body fluids samples in suspected cases of Extra Pulmonary Tuberculosis
Background: Diagnosis of extra-pulmonary tuberculosis (EPTB) in smear-negative patients can be difficult. We assessed prospectively the performance of Real Time PCR in diagnosing smear-negative tuberculosis (TB), which r...
Cardiac Metastasis of Primary Adenocarcinoma of Gall Bladder: Case Report
Primary tumors of heart are less common than secondary involvement. Isolated cardiac metastasis usually rare and mostly it is associated with wide spread of malignant tumor. Diagnosis of cardiac metastasis is difficult d...
Infant Feeding Practices in Rural Villages of Katihar District, Bihar
Hajipur, a remote village in the Katihar Block of Katihar District inhabited mainly by the poor, largely uneducated and underserved population.The backwardness of the village was the reason for selecting it for study. Ob...
Comparison of Hysterosalpingography and Laparoscopy in Evaluation of Tubal Factor as a Cause of Female Infertility
Introduction: Tubal factor contributes to 60% of female infertility in Indian women (Chaudhari AD et al., 2017). Hysterosalpingography (HSG) and laparoscopy are commonly used for assessment of tubal patency. The objectiv...